Comerica Bank Has $272,000 Stake in Core Laboratories Inc. $CLB

Comerica Bank trimmed its holdings in Core Laboratories Inc. (NYSE:CLB) by 4.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,133 shares of the oil and gas company’s stock after selling 873 shares during the period. Comerica Bank’s holdings in Core Laboratories were worth $272,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hotchkis & Wiley Capital Management LLC bought a new stake in Core Laboratories in the 1st quarter valued at $6,008,000. Nuveen LLC bought a new stake in Core Laboratories in the 1st quarter valued at $2,573,000. Raiffeisen Bank International AG bought a new stake in Core Laboratories in the 4th quarter valued at $1,706,000. Rice Hall James & Associates LLC lifted its position in Core Laboratories by 71.2% in the 1st quarter. Rice Hall James & Associates LLC now owns 193,798 shares of the oil and gas company’s stock valued at $2,905,000 after acquiring an additional 80,595 shares in the last quarter. Finally, Northern Trust Corp lifted its position in Core Laboratories by 15.6% in the 4th quarter. Northern Trust Corp now owns 577,752 shares of the oil and gas company’s stock valued at $10,001,000 after acquiring an additional 78,173 shares in the last quarter. 97.81% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CLB has been the topic of several research reports. Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 26th. Stifel Nicolaus lowered their price target on shares of Core Laboratories from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Citigroup lowered their price target on shares of Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 13th. Finally, Zacks Research upgraded Core Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, August 15th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $12.50.

Core Laboratories Stock Up 3.3%

Core Laboratories stock opened at $12.82 on Wednesday. The firm has a market capitalization of $601.13 million, a PE ratio of 20.68, a P/E/G ratio of 3.75 and a beta of 1.46. The company’s 50-day moving average is $11.52 and its 200-day moving average is $12.31. Core Laboratories Inc. has a fifty-two week low of $9.72 and a fifty-two week high of $21.83. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.27 and a quick ratio of 1.70.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.01. The company had revenue of $130.16 million for the quarter, compared to analyst estimates of $129.19 million. Core Laboratories had a net margin of 5.73% and a return on equity of 14.15%. Core Laboratories’s revenue for the quarter was down .3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 EPS. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. Sell-side analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 25th. Stockholders of record on Monday, August 4th were paid a dividend of $0.01 per share. The ex-dividend date was Monday, August 4th. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. Core Laboratories’s payout ratio is currently 6.45%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.